|
Real-time Estimate
Cboe Europe
11:26:57 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 53.35 CHF | +0.09% |
|
+3.89% | -49.24% |
| 10-21 | Cosmo N.V. - Special Call | |
| 10-19 | Cosmo Pharmaceuticals N.V. Reports Positive Phase 2 Study Results Of Rifamycin 1% Topically Acting Gel In Distal Ulcerative Colitis And Ulcerative Proctitis | CI |
Chart: Technical Analysis
Swiss ExchangeCHF
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| COPN | Delayed | |
CBOE
| 0RGI | Real-time | |
|
Tradegate
| C43 | Real-time | |
|
London S.E.
| 0RGI | Delayed | |
|
Boerse Muenchen
| C43 | Real-time | |
|
OTC Markets
| CMOPF | Delayed | |
|
Deutsche Boerse AG
| C43 | Delayed | |
|
Xetra
| C43 | Delayed | |
|
Börse Stuttgart
| C43 | Delayed | |
|
Wiener Boerse
| COPN | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 58.3 | 61.7 | 78.1 |
| Spread/Res. | -8.40% | -13.45% | -31.63% |
| Spread/Supp. | +8.98% | +8.98% | +3.89% |
| Support | 49 | 49 | 51.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COPN Stock
- Charts Cosmo N.V.
Select your edition
All financial news and data tailored to specific country editions
